Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

National, Multicenter, Observational Study Evaluating Prevalence, Virological and Clinical Characteristics of Chronic Hepatitis Delta in Romania and Assess Efficacy of Peg-interferon Alfa-2a Treatment in Patients With Chronic Hepatitis D (CHD)

Trial Profile

National, Multicenter, Observational Study Evaluating Prevalence, Virological and Clinical Characteristics of Chronic Hepatitis Delta in Romania and Assess Efficacy of Peg-interferon Alfa-2a Treatment in Patients With Chronic Hepatitis D (CHD)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2016

At a glance

  • Drugs Peginterferon alfa-2a (Primary)
  • Indications Hepatitis D
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 26 Oct 2016 Status changed from active, no longer recruiting to discontinued.
    • 20 Oct 2014 Planned End Date changed from 1 Mar 2015 to 1 Oct 2014 according to ClinicalTrials.gov record.
    • 14 Oct 2014 Planned End Date changed from 1 Oct 2014 to 1 Mar 2015 according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top